People and providers should balance these potential benefits with the risks, both known and unknown, as phase 3 clinical trials ensue
Goal of treatment: Ask whether the priority is A1C, weight, cardiovascular risk, or several goals
The TGA typically approves 6 to 18 months after FDA
Some sensitive patients may benefit from microdosing (below 0.25 mg) or customized compounded formulations to improve tolerance
Characterization of ANGPTL4 function in macrophages and adipocytes using Angptl4-knockout and Angptl4-hypomorphic mice
Plus, the amount of electrolytes, other than sodium, in pink salt is very small, says Allison Childress, PhD, RDN, CSSD, LD , an associate professor in the Nutritional Sciences Department at Texas Tech University